HumanOptics

DGAP-News: HumanOptics AG: CE-marking for innovative trifocal lens TRIVA(R)

DGAP-News: HumanOptics AG / Key word(s): Miscellaneous
HumanOptics AG: CE-marking for innovative trifocal lens TRIVA(R)

19.02.2020 / 16:39
The issuer is solely responsible for the content of this announcement.


HumanOptics: CE-marking for innovative trifocal lens TRIVA(R)

Erlangen, 18 February 2020 - HumanOptics AG has received CE marking and thus approval on the European market for its new trifocal lens TRIVA-aA. With this innovative intraocular lens (IOL), the specialist for high-quality ophthalmic surgery implants is expanding its range in the rapidly growing premium lens segment.

TRIVA-aA is the first multifocal lens from HumanOptics with three focal points. Its optimized design enables patients to enjoy good vision not only at long and near distances, but also at medium distances. It is therefore particularly suitable for screen work or the use of tablets and smartphones and is tailored to the requirements of a modern, digital living environment in today's society.

The novel lens is used in cataract surgery, which is becoming increasingly important due to demographic developments. Cataract surgery is getting an increasingly refractive character, which means that in addition to cataracts, ametropia is also corrected.

The novel trifocal lenses are produced with high-precision sub-nano resolution (SNR) technology in Germany. This technology, which can only be realized by using appropriate ultra-precision lathes and makes subsequent polishing superfluous, makes HumanOptics the world leader.

Company profile:

HumanOptics AG () specializes in the development, production and sale of high-quality implants and accessories for ophthalmic surgery and stands for the highest quality and innovative strength in this segment. The most important products are intraocular lenses (IOL) for the treatment of cataracts and various forms of ametropia as well as artificial irises. In addition, the company offers the operating ophthalmologists accessories and complementary products as well as comprehensive consulting services. The shares of HumanOptics AG are listed on the Basic Board of the Frankfurt Stock Exchange.

Contact us:

HumanOptics AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Germany
Phone: +49 (0) 9131 50665-0
E-Mail:



19.02.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: HumanOptics AG
Spardorfer Str. 150
91054 Erlangen
Germany
Phone: +49 (0)9131 - 50665-60
Fax: +49 (0)9131 - 50665-93
E-mail:
Internet:
ISIN: DE000A1MMCR6, DE000A255FK8
WKN: A1MMCR
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart
EQS News ID: 979341

 
End of News DGAP News Service

979341  19.02.2020 

fncls.ssp?fn=show_t_gif&application_id=979341&application_name=news&site_id=research_pool
EN
19/02/2020

Reports on HumanOptics

 PRESS RELEASE

DGAP-News: HumanOptics AG: Merger Squeeze-out registered

DGAP-News: HumanOptics AG / Key word(s): Squeeze Out HumanOptics AG: Merger Squeeze-out registered 12.11.2021 / 14:14 The issuer is solely responsible for the content of this announcement. HumanOptics AG: Merger Squeeze-out registered November 12, 2021: HumanOptics Holding AG, Erlangen ("HOH"), and HumanOptics AG, Erlangen ("HO"), have signed a merger agreement on May 25, 2021, which provides for the exclusion of the remaining shareholders of HO (minority shareholders) in connection with the merger. On July 6, 2021, the extraordinary general meeting of HO resolved to tr...

 PRESS RELEASE

DGAP-News: HumanOptics AG: Verschmelzungsrechtlicher Squeeze-out einge...

DGAP-News: HumanOptics AG / Schlagwort(e): Squeeze-Out HumanOptics AG: Verschmelzungsrechtlicher Squeeze-out eingetragen 12.11.2021 / 14:14 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. HumanOptics AG: Verschmelzungsrechtlicher Squeeze-out eingetragen 12. November 2021: Die HumanOptics Holding AG, Erlangen ("HOH"), und die HumanOptics AG, Erlangen ("HO"), haben am 25. Mai 2021 einen Verschmelzungsvertrag geschlossen, der die Angabe enthält, dass im Zusammenhang mit der Verschmelzung ein Ausschluss der übrigen Aktionäre der HO (Minderheitsa...

 PRESS RELEASE

DGAP-News: HumanOptics AG: Zulassung für innovative Trifokal-Linse TR...

DGAP-News: HumanOptics AG / Schlagwort(e): Sonstiges HumanOptics AG: Zulassung für innovative Trifokal-Linse TRIVA(R) 19.02.2020 / 16:39 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. HumanOptics: Zulassung für innovative Trifokal-Linse TRIVA(R) Erlangen, 18. Februar 2020 - Die HumanOptics AG hat die CE-Kennzeichnung und damit die Zulassung am europäischen Markt für ihre neue Trifokal-Linse TRIVA-aA erhalten. Mit dieser innovativen Intraokularlinse (IOL) erweitert der Spezialist für hochwertige Augenchirurgie-Implantate sein Angebot i...

 PRESS RELEASE

DGAP-News: HumanOptics AG: CE-marking for innovative trifocal lens TRI...

DGAP-News: HumanOptics AG / Key word(s): Miscellaneous HumanOptics AG: CE-marking for innovative trifocal lens TRIVA(R) 19.02.2020 / 16:39 The issuer is solely responsible for the content of this announcement. HumanOptics: CE-marking for innovative trifocal lens TRIVA(R) Erlangen, 18 February 2020 - HumanOptics AG has received CE marking and thus approval on the European market for its new trifocal lens TRIVA-aA. With this innovative intraocular lens (IOL), the specialist for high-quality ophthalmic surgery implants is expanding its range in the rapidly growing premium ...

 PRESS RELEASE

DGAP-News: HumanOptics AG: Artificial iris from HumanOptics receives U...

DGAP-News: HumanOptics AG / Key word(s): Miscellaneous HumanOptics AG: Artificial iris from HumanOptics receives US health insurance approval 23.01.2020 / 11:00 The issuer is solely responsible for the content of this announcement. Artificial iris from HumanOptics receives US health insurance approval Important step towards expanding market position Erlangen, 23 January 2020 - HumanOptics AG has received health insurance approval for its artificial iris CUSTOMFLEX(R) ArtificialIris in the USA. The specialist for high-quality eye surgery implants is thus further improvi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch